Antaros Tracer - a sister company to Antaros Medical

Antaros Tracer was formed to ensure an expedited and focused development of new Positron Emission Tomography (PET) tracers to be used as important biomarkers in drug development studies. Current disease area focus is fibrotic disease and immune-system activation in immuno-oncology, inflammatory disease, and immunology.


Per Hagmar
Chief Executive Officer
+46 70 3962616


Olof Eriksson
Chief Scientific Officer
+46 70 7903054